do not combine dpp-4 inhibitor with glp-1 receptor agonist guideline Frontiers do not combine glp-1 receptor

If you are switching between weekly medications, you should not administer two medications in the same week

Packaging and label may vary

However, future research should investigate the potential of GLP-1RAs in autoimmune and fibrotic diseases, assess their combination with other anti-inflammatory agents to enhance synergistic effects, and conduct long-term, head-to-head trials to compare efficacy, safety, and tolerability across different GLP-1-based therapies

N Engl J Med (2016) 375:183444

GLP-1 receptor agonists' impact on cardio-renal outcomes and mortality in T2D with acute kidney disease

Triple-Hormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial